AddLife AB (publ) (ALIF-B.ST)
SEK 137.2
(2.39%)
SEK 137.2
(2.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 585 Million SEK | -33.29% |
| 2022 | 808 Million SEK | -18.9% |
| 2021 | 996.3 Million SEK | 48.15% |
| 2020 | 672.5 Million SEK | 242.76% |
| 2019 | 196.2 Million SEK | 16.99% |
| 2018 | 167.7 Million SEK | 1.08% |
| 2017 | 165.9 Million SEK | 18.42% |
| 2016 | 140.1 Million SEK | 31.8% |
| 2015 | 106.3 Million SEK | -25.51% |
| 2014 | 142.7 Million SEK | 37.34% |
| 2013 | 103.9 Million SEK | 5.38% |
| 2012 | 98.6 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 192 Million SEK | 2.67% |
| 2024 Q3 | 114 Million SEK | -40.63% |
| 2024 Q1 | 187 Million SEK | 59.83% |
| 2023 Q1 | 258 Million SEK | 73.15% |
| 2023 Q3 | 132 Million SEK | -2.94% |
| 2023 Q2 | 136 Million SEK | -47.29% |
| 2023 FY | 539 Million SEK | -33.29% |
| 2023 Q4 | 117 Million SEK | -11.36% |
| 2022 Q4 | 149 Million SEK | 47.52% |
| 2022 Q2 | 48 Million SEK | -80.0% |
| 2022 Q1 | 240 Million SEK | -2.16% |
| 2022 FY | 808 Million SEK | -18.9% |
| 2022 Q3 | 101 Million SEK | 110.42% |
| 2021 Q4 | 245.3 Million SEK | 18.5% |
| 2021 FY | 996.3 Million SEK | 48.15% |
| 2021 Q1 | 291 Million SEK | 4.49% |
| 2021 Q2 | 253 Million SEK | -13.06% |
| 2021 Q3 | 207 Million SEK | -18.18% |
| 2020 FY | 672.5 Million SEK | 242.76% |
| 2020 Q4 | 278.5 Million SEK | 64.79% |
| 2020 Q3 | 169 Million SEK | 11.92% |
| 2020 Q2 | 151 Million SEK | 104.05% |
| 2020 Q1 | 74 Million SEK | 1.09% |
| 2019 Q4 | 73.2 Million SEK | 103.33% |
| 2019 Q1 | 45 Million SEK | -17.73% |
| 2019 Q3 | 36 Million SEK | -14.29% |
| 2019 Q2 | 42 Million SEK | -6.67% |
| 2019 FY | 196.2 Million SEK | 16.99% |
| 2018 Q2 | 43 Million SEK | 10.26% |
| 2018 FY | 167.7 Million SEK | 1.08% |
| 2018 Q4 | 54.7 Million SEK | 76.45% |
| 2018 Q3 | 31 Million SEK | -27.91% |
| 2018 Q1 | 39 Million SEK | -34.89% |
| 2017 Q2 | 40 Million SEK | 0.0% |
| 2017 FY | 165.9 Million SEK | 18.42% |
| 2017 Q3 | 26 Million SEK | -35.0% |
| 2017 Q1 | 40 Million SEK | -37.79% |
| 2017 Q4 | 59.9 Million SEK | 130.38% |
| 2016 Q2 | 36.5 Million SEK | 65.16% |
| 2016 Q3 | 21.3 Million SEK | -41.64% |
| 2016 Q1 | 22.1 Million SEK | -34.23% |
| 2016 Q4 | 64.3 Million SEK | 201.88% |
| 2016 FY | 140.1 Million SEK | 31.8% |
| 2015 FY | 106.3 Million SEK | -25.51% |
| 2015 Q3 | 16.6 Million SEK | -44.48% |
| 2015 Q4 | 33.6 Million SEK | 102.41% |
| 2015 Q1 | 60.8 Million SEK | 75.72% |
| 2015 Q2 | 29.9 Million SEK | -50.82% |
| 2014 FY | 142.7 Million SEK | 37.34% |
| 2014 Q4 | 34.6 Million SEK | 0.0% |
| 2013 FY | 103.9 Million SEK | 5.38% |
| 2012 FY | 98.6 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biotage AB (publ) | 376 Million SEK | -55.585% |
| Bonesupport Holding AB (publ) | 13.93 Million SEK | -4099.569% |
| Doxa AB (publ) | 269.4 Million SEK | -117.149% |
| Elekta AB (publ) | 2.03 Billion SEK | 71.309% |
| iZafe Group AB (publ) | -35.63 Million SEK | 1741.644% |
| Ortivus AB (publ) | -17.61 Million SEK | 3421.599% |
| Ortivus AB (publ) | -17.61 Million SEK | 3421.599% |
| Q-linea AB (publ) | -230.58 Million SEK | 353.7% |
| S2Medical AB (publ) | -15.26 Million SEK | 3932.581% |
| Synsam AB (publ) | 696 Million SEK | 15.948% |